Verus Capital Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $594K | Buy |
8,599
+4,876
| +131% | +$337K | 0.05% | 209 |
|
|
2025
Q1 | $259K | Sell |
3,723
-241
| -6% | -$16.7K | 0.02% | 332 |
|
|
2024
Q4 | $341K | Sell |
3,964
-2,545
| -39% | -$219K | 0.03% | 282 |
|
|
2024
Q3 | $775K | Buy |
6,509
+1,408
| +28% | +$168K | 0.07% | 160 |
|
|
2024
Q2 | $728K | Sell |
5,101
-388
| -7% | -$55.4K | 0.07% | 161 |
|
|
2024
Q1 | $705K | Sell |
5,489
-665
| -11% | -$85.4K | 0.08% | 147 |
|
|
2023
Q4 | $637K | Buy |
6,154
+1,507
| +32% | +$156K | 0.08% | 143 |
|
|
2023
Q3 | $423K | Buy |
+4,647
| New | +$423K | 0.06% | 182 |
|
|
2020
Q1 | $78K | Hold |
2,600
| – | – | 0.02% | 372 |
|
|
2019
Q4 | $75K | Buy |
+2,600
| New | +$75K | 0.02% | 469 |
|